AI assistant
Sending…
Ernexa Therapeutics Inc. — Director's Dealing 2016
Jun 9, 2016
35259_dirs_2016-06-09_5aecd7be-b78b-49cc-be2a-6c7535402029.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NTN BUZZTIME INC (NTN)
CIK: 0000748592
Period of Report: 2016-06-08
Reporting Person: Miller Dave Brian (SVP Marketing)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-08 | Common Stock | P | 30000 | $0.12 | Acquired | 140000 | Direct |
More from Ernexa Therapeutics Inc.
Major Shareholding Notification
2026
May 14
Annual Report
2026
May 11
Proxy Solicitation & Information Statement
2026
May 11
Proxy Solicitation & Information Statement
2026
May 11
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 24